Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
Government of Canada invests $4M in McMaster to fast-track drug discovery initiatives
McMaster University has received $4 million in federal funding to upgrade and significantly expand its drug discovery infrastructure. With the new investment from the Federal . . .
Two McMaster projects get $300,000 in federal funding for bird flu research
Two McMaster research teams have received catalyst grants worth a total of $300,000 from the Canadian Institutes of Health Research (CIHR) to study H5N1 avian . . .
The ‘ant’ in antibiotic discovery: How insects could be the key to fighting superbugs
A McMaster researcher is studying an eons-old relationship between ants, fungi, and bacteria in a quest for new drugs to combat antimicrobial resistance, one of . . .
Discover how Our Research is making an Impact
